<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315818</url>
  </required_header>
  <id_info>
    <org_study_id>MIF</org_study_id>
    <nct_id>NCT04315818</nct_id>
  </id_info>
  <brief_title>The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis</brief_title>
  <official_title>The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rheumatoid Arthritis is a chronic debilitating inflammatory autoimmune disease of unknown
      etiology .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although the pathogenesis of Rheumatoid Arthritis is multifactorial, the contribution of
      cytokines is undoubtedly pivotal in the progression of the inflammatory process. One cytokine
      gaining recognition for its importance in the inflammatory process is Macrophage migration
      inhibitory factor .

      Macrophage Migration Inhibitory Factor is a multipotent cytokine involved in a broad range of
      functions including induction of proinflammatory mediators as well as demonstrated roles in
      both innate and adaptive immunity. It was originally identified in the culture medium of
      activated T lymphocytes as a soluble factor that inhibit random migration of macrophages .

      Macrophage Migration Inhibitory Factor induces synoviocytes expression of key proinflammatory
      genes including TNF, IL-1, IL-6, IL-8. Moreover, it also regulates the function of
      endothelial cells and B cells and is implicated in the control of synoviocytes proliferation
      and apoptosis via direct effects on the expression of the tumor suppressor protein P53. In
      Rheumatoid Arthritis, increased Macrophage Migration Inhibitory Factor levels have been
      demonstrated in serum, synovial fluid and tissue correlating with disease activity.

      Hydroxyapatite 25 vitamin D3 is a hormone primarily synthesized in human skin under the
      stimulation of ultraviolet radiation. Beyond its endocrine role in bone metabolism, Vitamin
      D3 is endowed with remarkable immunomodulatory properties. The effects of Vitamin D3 on the
      immune system include the enhancement of microbicidal ability of monocytes macrophages and
      the down-modulation of inflammatory cytokines produced by T lymphocytes.

      Some epidemiological studies have reported an inverse association between serum 25(OH)vitamin
      D3 concentrations and Rheumatoid Arthritis disease activity and severity. In addition, some
      studies have reported inverse correlations between serum 25(OH)vitamin D3 and circulating
      inflammatory markers and cytokines.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis</measure>
    <time_frame>october,2022</time_frame>
    <description>evaluate the role of Macrophage Migration Inhibitory Factor serum levels in Rheumatoid Arthritis and its relation with disease activity.
evaluate the role of 25(OH)vitamin D3 serum levels in Rheumatoid Arthritis patients and its relation to disease severity.
detect the relationship between Macrophage Migration Inhibitory Factor and 25(OH)vitamin D3 serum levels in Rheumatoid Arthritis patients</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>expermintal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>placebo</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient aged 18 or older and satisfying 2010 ACR/ EULAR Rheumatoid Arthritis
        classification criteria will be included
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient aged 18 or older

          -  satisfying 2010 ACR/ EULAR Rheumatoid Arthritis classification criteria will be
             included .

        Exclusion Criteria:

          -  Any patient with arthritis other than Rheumatoid Arthritis

          -  Individuals with other autoimmune diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Doaa Kamal, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eman Ahmed, professor</last_name>
    <phone>01066643425</phone>
    <email>e_omran@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marwa Ahmed, Assistant professor</last_name>
    <phone>01006783422</phone>
    <email>marwa.a.galal@aun.edu.eg</email>
  </overall_contact_backup>
  <reference>
    <citation>Santos LL, Morand EF. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Wien Med Wochenschr. 2006 Jan;156(1-2):11-8. Review.</citation>
    <PMID>16465610</PMID>
  </reference>
  <reference>
    <citation>Kim KW, Kim HR. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis. Korean J Intern Med. 2016 Jul;31(4):634-42. doi: 10.3904/kjim.2016.098. Epub 2016 May 12. Review.</citation>
    <PMID>27169879</PMID>
  </reference>
  <reference>
    <citation>Llamas-Covarrubias MA, Valle Y, Navarro-Hernández RE, Guzmán-Guzmán IP, Ramírez-Dueñas MG, Rangel-Villalobos H, Estrada-Chávez C, Muñoz-Valle JF. Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course. Rheumatol Int. 2012 Aug;32(8):2307-11. doi: 10.1007/s00296-011-1951-6. Epub 2011 May 24.</citation>
    <PMID>21607559</PMID>
  </reference>
  <reference>
    <citation>Ishikawa LLW, Colavite PM, Fraga-Silva TFC, Mimura LAN, França TGD, Zorzella-Pezavento SFG, Chiuso-Minicucci F, Marcolino LD, Penitenti M, Ikoma MRV, Sartori A. Vitamin D Deficiency and Rheumatoid Arthritis. Clin Rev Allergy Immunol. 2017 Jun;52(3):373-388. doi: 10.1007/s12016-016-8577-0. Review.</citation>
    <PMID>27484684</PMID>
  </reference>
  <reference>
    <citation>Bilsborrow JB, Doherty E, Tilstam PV, Bucala R. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Expert Opin Ther Targets. 2019 Sep;23(9):733-744. doi: 10.1080/14728222.2019.1656718. Epub 2019 Aug 20. Review.</citation>
    <PMID>31414920</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 18, 2020</study_first_submitted>
  <study_first_submitted_qc>March 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Marwa Maher Abdelaziz</investigator_full_name>
    <investigator_title>principal investegator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

